Latest Breaking News On - Source nrx pharmaceuticals - Page 1 : vimarsana.com

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression -January 22, 2024 at 06:49 am EST

Exceeded originally target enrollment with n=74 Last patient, last visit expected in approximately six weeks; data to follow shortly thereafterPositive.

United statesAndrew nierenbergJonathan javittAlvogen pharmaceuticalsPrnewswire nrx pharmaceuticals incNrxp nrx pharmaceuticalsUs national institutes of healthNrx pharmaceuticals incSource nrx pharmaceuticalsNrx pharmaceuticalsSuicidal treatment resistant bipolarBreakthrough therapy designationChief scientistPrincipal investigatorHarvard massachusetts generalClinical global impression suicidality scale

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination -January 17, 2024 at 06:49 am EST

RADNOR, Pa., Jan. 17, 2024 /PRNewswire/ NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for suicidal depression, chronic pain, and PTSD, today.

Stephen willardNasdaq hearings panel theUs national institutes of healthAlvogen pharmaceuticalsNrx pharmaceuticalsSource nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incNasdaq stock marketNrx pharmaceuticals incNasdaq hearings panelNasdaq capital marketCapital marketCorporate presentationNew drug applicationBreakthrough therapyFast track designation

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis

NRx Pharmaceuticals, Inc (Nasdaq: NRXP) Announces FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation of NRX-101 in Complicated Urinary Tract Infection and Pyelonephritis
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan javittMichael manyakUs national institutes of healthNrxp nrx pharmaceuticalsForum infectious diseasesNrx pharmaceuticalsSource nrx pharmaceuticalsCompany new drug applicationAlvogen pharmaceuticalsPrnewswire nrx pharmaceuticals incNrx pharmaceuticals incInfectious disease productFast track designationComplicated urinary tract infectionPriority review

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatm

NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatm
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJonathan javittMichael grunebaumNrx pharmaceuticals incAlvogen pharmaceuticalsNephron pharmaceuticalsColumbia universityNrx pharmaceuticalsNrxp nrx pharmaceuticalsUs national institutes of healthSource nrx pharmaceuticalsPrnewswire nrx pharmaceuticals incNew drug applicationLicense dataTechnical information agreement

NRx Pharmaceuticals Announces Further Alignment with FDA on Initiation of Registrational Trials for NRX-101 in the Treatment of Chronic Pain

Study May Proceed letter received from FDAIND preclinical requirements are consistent with studies already in progress to support treatment of Bipolar DepressionPotential to initiate registrational.

Stephen willardNrxp nrx pharmaceuticalsNrx pharmaceuticalsDivision of psychiatry productsPrnewswire nrx pharmaceuticals incSource nrx pharmaceuticalsDivision of anesthesiologyCompany quarterly reports on formAlvogen pharmaceuticalsExchange commissionAddiction medicinePain medicineInvestigational new drugPsychiatry productsBipolar depressionChronic pain